ONWARD Medical reports Q3 2026 revenue of €2.5M, ARC-EX volumes up 120%

ONWARD Medical N.V. reported Q3 2026 revenue of €2.5 million, with €2.0 million from its ARC-EX platform, and €73.4 million in cash. ARC-EX unit volumes rose 120% year over year, with continued clinical progress in spinal cord injury, bladder control and Parkinson's-related blood pressure instability.

Detected & updated continuously · Source: Nebula